Background Clear national and trust guidelines are available regarding the management of
patients receiving anticoagulation therapy (warfarin and low molecular weight heparin …

Aims: To evaluate the evidence of therapeutic international normalised ratio (INR) control
reporting and to provide recommendations for future reporting, particularly for research and …

Anticoagulants, commonly prescribed agents for the prevention and treatment of
thromboembolism, have the highest rate of medication-related adverse drug events (ADEs) …

Purpose Anticoagulation-associated adverse drug events are common in hospitalised
patients and result in morbidity, mortality, increased length of hospital stay and higher costs …

Introduction: The quality of anticoagulation management is not readily or frequently
assessed, particularly between different centres. This study sought to evaluate agreement in …

Background Poor monitoring of anticoagulants is a significant area of patient safety. It can
lead to the dichotomous risk of haemorrhage/clotting without appropriate counselling and …

Background: Patients taking anticoagulants orally over the long term have international
normalized ratios (INRs) outside the individual therapeutic range more than one-third of the …

Objectives Time within therapeutic INR range (TTR) predicts benefits/risk of warfarin therapy.
Identification of individual‐and centre‐related factors that influence TTR, and addressing …

Background: Even with the introduction of direct oral anticoagulants (DOACs),
anticoagulation clinics (ACs) stand with a key role in monitoring. Indeed, routine evaluation …

Warfarin remains the gold standard oral anticoagulant for the prevention and treatment of
thromboembolic disease. Effective warfarin management comprises:• regular, accurate and …